Monitoring relapses in MS patients after surgery
Official title: Assessment of Risk of Postoperative Relapses in Patients With Multiple Sclerosis; an Observational Study
Run by University of Athens · NCT04237675 · Data updated 2026-11-12
This study looks at how surgery and anesthesia might affect the chances of relapse in people with Multiple Sclerosis during the year after their operation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | University of Athens Academic / other |
| Locations | 2 sites (Athens, Attica and 1 other locations) |
| Status | Recruiting |
| Started | December 20, 2019 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | January 23, 2020 |
| Trial ID | NCT04237675 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with Multiple Sclerosis who are scheduled for surgery requiring anesthesia.
✕Probably not a fit
Patients who do not have a diagnosis of Multiple Sclerosis or who refuse to participate will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to track the occurrence of relapses in patients diagnosed with Multiple Sclerosis (MS) during the year following surgical procedures involving general or regional anesthesia. The study will collect data on any relapses experienced by these patients postoperatively, providing insights into the relationship between surgery, anesthesia, and MS relapse rates. By focusing on this specific patient population, the study seeks to enhance understanding of postoperative outcomes in MS patients.
Why it matters
Potential benefit: If successful, this study could help identify risk factors for relapses in MS patients undergoing surgery, leading to improved management strategies.
How similar studies have gone: While there may be limited studies specifically addressing this topic, the approach of monitoring postoperative outcomes in chronic conditions like MS has shown promise in related research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: diagnosed MS - Exclusion Criteria: refuse to participate \-
Where it's running
-
Aretaieio Hospital, University of Athens
Athens, Attica, Greece Recruiting -
Aretaieio Hospital
Athens, Greece Recruiting
Study contacts
- Study coordinator: Chryssoula V Staikou, Assoc Prof
- Email: c_staikou@yahoo.gr
- Phone: 00302107780172
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Assessing the effects of Clemastine Fumarate on myelin repair in MS patients
This study is testing if a medication called Clemastine Fumarate can help repair the protective covering of nerves in people with relapsing-remitting multiple sclerosis.
-
SGLT2 inhibitor effects on artery stiffness, vessel lining thickness, and heart muscle after a heart attack
This project will see if SGLT2 inhibitors given after a heart attack improve blood vessel stiffness, the vessel's protective lining, and heart muscle function for people with type 2 diabetes or reduced heart pumping.
-
How Lipoprotein(a) affects artery stiffness, blood vessel lining, and heart muscle movement
This project will see if higher Lipoprotein(a) levels are linked to stiffer arteries, worse endothelial function, and changes in left atrial and left ventricular motion in adults 18–75.
-
ICU clinician burnout before and during a tele-palliative-care program
This project will test if a tele-palliative-care program and training reduce burnout in ICU doctors, nurses, and psychologists.
-
Using flecainide to treat frequent premature ventricular contractions and related heart issues
This study is testing if the heart medication flecainide can help adults with frequent heartbeats and related heart issues who can't or don't want to have a procedure called catheter ablation.
-
Cytisine treatment for helping smokers quit and its effects on heart health
This study tests if a plant-based treatment called cytisine can help adult smokers quit and also looks at how it affects their heart health during and after the treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.